ISSN: 2475-7640

Journal de transplantation clinique et expérimentale

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Huntington's disease Stem Cell Transplantation?s Potential Therapeutic Application and Pathogenesis

Diana Jacobs

Repetitive CAG or glutamine expression along the Huntington gene’s coding region results in the progressive neurodegenerative disorder known as Huntington’s disease (HD). Certain abnormalities in movement, emotional disturbances, dementia, and cognitive impairments are the effects of this disease. To this date, there could be no legitimate remedy for this uncommon and deadly neurological condition yet there have been sure headways in the field of hereditary creature model examination studies to explain the comprehension of the pathogenesis of this condition. Currently, HD follows a specific therapeutic approach that only treats symptoms and does not address the disease’s underlying cause. Stem cell therapy has the potential to be a game-changer in the search for a cure. The pathogenesis, efficacy, and clinical viability of the therapeutic application of stem cell transplantation in Huntington’s disease have all been discussed in this review. A brief list and analysis of the applications of this revolutionary therapy on genetically modified animal models has been provided.